Uzbekistan Hepatitis Elimination Project (UHEP)







disease burden

Uzbekistan Disease Burden

HBV and HCV Disease Burden and Economic Impact

In 2016, our Polaris Observatory collaborated with the Uzbekistan Ministry of Health and national stakeholders to analyze HBV and HCV disease burden and economic impact, and to develop national strategies to achieve elimination.  

Uzbekistan has a population of 30 million, with an estimated 2.5 million (8.3%) persons living with HBV infection (HBsAg positive), of whom only 10% have been diagnosed and only 0.5% have been treated as of 2016.  

Similarly, an estimated 1.3 million (4.3%) persons are living with HCV infection (RNA positive) of whom only 5% were diagnosed and only 2% were treated as of 2016.   

fig1
fig2

en_USEnglish